arrow
M

Małgorzata Firczuk

Medical University of Warsaw
H指数:25
被引数:2,545

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

mTORC1 inhibition upregulates CD20 and enhances anti-CD20 antibody efficacy in B-cell precursor acute lymphoblastic leukemia

mTORC1抑制上调CD20并增强抗CD20抗体在B细胞前体急性淋巴细胞白血病中的疗效

Leukemia
IF13.4
2026-08-190
OA
LILRB1-directed CAR-T cells for the treatment of hematological malignancies

LILRB1靶向CAR-T细胞用于治疗血液系统恶性肿瘤

LEUKEMIA
IF13.4
2025-04-050
OA
Asciminib stands out as the superior tyrosine kinase inhibitor to combine with anti-CD20 monoclonal antibodies for the treatment of CD20+Philadelphia-positive B-cell precursor acute lymphoblastic leukemia in preclinical models
2024-06-060
OAAI
CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies
2024-06-040
OA
A Specific CD44lo CD25lo Subpopulation of Regulatory T Cells Inhibits Anti-Leukemic Immune Response and Promotes the Progression in a Mouse Model of Chronic Lymphocytic Leukemia
2022-02-285
OAAI
Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax
2022-01-2812
OAAI
Fluctuations in circulating endothelial progenitor cell levels and acute cardiac graft rejection

循环内皮祖细胞水平的波动与急性心脏移植排斥反应

2019-11-280
OA
Targeting the thioredoxin system as a novel strategy against B-cell acute lymphoblastic leukemia
2019-04-0529
OAAI
Inhibition of thioredoxin-dependent H2O2 removal sensitizes malignant B-cells to pharmacological ascorbate
2019-02-0133
OAAI